Intended use
Test for the quantitative determination of urea in blood, serum or plasma with Reflotron.
Clinical aspects
Urea is determined for the evaluation of renal function. The test is often used together with the determination of creatinine for differentiation between prerenal and postrenal azotaemia on the basis of the urea/creatinine ratio. Other indications for the determination of urea are end-stage renal failure and determination in dialysis patients as the urea concentration is representative for protein breakdown and provides information on the metabolic status.
Available in a tube of 15 test/strips.
| Μονάδα Πώλησης | |
|---|---|
| SECTION | |
| COMPANY | |
| Αναλυτής |
Related products
DRY CHEMISTRY
Intended use Test for quantitative determination of the total activity of alkaline phosphatase (EC 3.1.3.1.) from blood, serum, [...]
DRY CHEMISTRY
Intended use Test for the quantitative determination of creatinine in blood, serum, plasma or urine with Reflotron®. Clinical [...]
DRY CHEMISTRY
Intended use Test for the quantitative determination of total bilirubin in blood, serum or plasma with Reflotron systems. [...]
DRY CHEMISTRY
Intended use Test for the quantitative determination of GOT (AST; ASAT; EC 2.6.1.1) in blood, serum or plasma [...]
DRY CHEMISTRY
Intended use Test for the quantitative determination of potassium in heparinized plasma or serum with Reflotron. Clinical aspects [...]
DRY CHEMISTRY
Intended use Test for the quantitative determination of triglycerides in blood, serum or plasma with Reflotron®. Clinical aspects [...]
